Maynard Um
-
-
-
-
-
-
-
Cosmos Health reports Q3 revenue exceeds $17 million amid US expansion
-
-
-
-
-
-
-
Cosmos Health (COSM) files $200M mixed shelf
-
-
-
-
-
-
-
Cosmos Health launches U.S. nutraceuticals operations with Sky Premium Life
-
-
-
-
-
-
-
Cosmos Health (COSM) Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates
-
-
-
-
-
-
-
Cosmos Health Advances Cancer Treatment Innovation with Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market
-
-
-
-
-
-
-
Cosmos Health (COSM) Files New AI-Driven Patent Application for Multiple Sclerosis Treatment, Targeting $25 Billion+ Global Market
-
-
-
-
-
-
-
Cosmos Health Signs Expanded Exclusive Distribution Agreement with Virax Biolabs for Avian Influenza Virus PCR Kits in Saudi Arabia, the UAE, Qatar, and Kuwait
-
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

